XLONIUG
Market cap52mUSD
Dec 27, Last price
12.70GBP
1D
-0.39%
1Q
23.90%
IPO
-77.91%
Name
Intelligent Ultrasound Group PLC
Chart & Performance
Profile
Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators and clinical ultrasound software in the United Kingdom, North America, and internationally. It provides ScanNav Assist, an AI-based ultrasound software products that provide real-time image analysis during protocol-based scanning in the women's health sector; ScanNav Anatomy Peripheral Nerve Block (PNB), an AI based ultrasound software, which can automatically identify and highlight key anatomical structures in a live ultrasound image; and ScanNav Detect, which facilitate the automatic recognition of abnormalities within a general medical ultrasound scan. The company also offers ScanNav HealthCheck, an ultrasound software products that aims to enable ultrasound scans to be performed at home; ScanTrainer, an educational tool that uses real patient scans and curriculum-based teaching across obstetrics, gynecology, general medicine, and emergency medicine; ScanNav Anatomy PNB Trainer to teach ultrasound-guided needling to medical professionals; BodyWorks Eve, an ultra-realistic female patient simulator designed for interactive?point of care ultrasound scenario training; and NeedleTrainer, an augmented reality needling for non-invasive, safe, and realistic ultrasound-guided needling training. In addition, it provides BabyWorks, a baby manikin training tool for point of care ultrasound and echocardiography in pediatric and neonatal care; HeartWorks, a highly realistic simulator with all the tools needed to learn echocardiography; BodyWorks, a hi-fidelity simulator used in critical care, intensive care, and emergency medicine; and ORSIM, a simulator designed to teach advanced bronchoscopy skills in a virtual environment. The company was formerly known as MedaPhor Group plc and changed its name to Intelligent Ultrasound Group plc in January 2019. Intelligent Ultrasound Group plc was founded in 2004 and is headquartered in Cardiff, the United Kingdom.
IPO date
Aug 27, 2014
Employees
65
Domiciled in
GB
Incorporated in
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 11,173 10.62% | 10,100 32.96% | 7,596 46.92% | |||||||
Cost of revenue | 14,202 | 16,980 | 15,160 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (3,029) | (6,880) | (7,564) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (441) | (718) | (758) | |||||||
Tax Rate | ||||||||||
NOPAT | (2,588) | (6,162) | (6,806) | |||||||
Net income | (2,582) -13.47% | (2,984) -17.34% | (3,610) 9.20% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 5,200 | 13 | ||||||||
BB yield | -23.18% | -0.03% | ||||||||
Debt | ||||||||||
Debt current | 244 | 188 | 213 | |||||||
Long-term debt | 1,136 | 784 | 1,127 | |||||||
Deferred revenue | 272 | 209 | 320 | |||||||
Other long-term liabilities | 65 | 65 | 65 | |||||||
Net debt | (1,712) | (6,255) | (3,671) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (1,711) | (684) | (1,819) | |||||||
CAPEX | (338) | (1,824) | (1,778) | |||||||
Cash from investing activities | (2,121) | (1,823) | (1,777) | |||||||
Cash from financing activities | (236) | 4,548 | (219) | |||||||
FCF | (3,976) | (5,381) | (7,007) | |||||||
Balance | ||||||||||
Cash | 3,031 | 7,166 | 4,950 | |||||||
Long term investments | 61 | 61 | 61 | |||||||
Excess cash | 2,533 | 6,722 | 4,631 | |||||||
Stockholders' equity | (20,471) | (24,582) | (22,778) | |||||||
Invested Capital | 31,234 | 37,108 | 33,373 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 326,870 | 275,274 | 269,965 | |||||||
Price | 0.09 14.72% | 0.08 -46.56% | 0.15 5.17% | |||||||
Market cap | 30,562 36.23% | 22,435 -45.51% | 41,170 11.38% | |||||||
EV | 28,850 | 16,180 | 37,499 | |||||||
EBITDA | (1,414) | (5,496) | (6,376) | |||||||
EV/EBITDA | ||||||||||
Interest | 29 | 31 | 37 | |||||||
Interest/NOPBT |